Clinical Trial: Post-marketing study to assess the effectiveness and safety of RECARBRIO in Chinese adult patients with limited or no alternative treatment options for susceptible Gramnegative bacterial infections (China)

Posted On: 2026-10-26

China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Post-marketing study to assess the effectiveness and safety of RECARBRIO in Chinese adult patients with limited or no alternative treatment options for susceptible Gramnegative bacterial infections'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135084

Registration Time: 2026/10/23

Type: Observational study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349081

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Post-marketing study to assess the effectiveness and safety of RECARBRIO in Chinese adult patients with limited or no alternative treatment options for susceptible Gramnegative bacterial infections (China)